Academic Article

Academic Article RDF

Activated protein C and ischemic stroke
Activated protein C anticoagulant activity is enhanced by skeletal muscle myosin
Activated Protein C Attenuates Experimental Autoimmune Encephalomyelitis Progression by Enhancing Vascular Integrity and Suppressing Microglial Activation
Activated protein c blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
Activated protein c correlates inversely with thrombin levels in resting healthy individuals
Activated protein C in neuroprotection and malaria
Activated protein c in sepsis: The promise of nonanticoagulant activated protein c
Activated protein C in the cardioplegic solution on a porcine model of coronary ischemia-reperfusion has deleterious hemodynamic effects
Activated protein C inhibits neutrophil extracellular trap formation in vitro and activation in vivo
Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage
Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells
Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S
Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions
Activated protein C plasma levels in the fasting and postprandial states among patients with previous unprovoked venous thromboembolism
Activated protein C preserves functional islet mass after intraportal transplantation - a novel link between endothelial cell activation, thrombosis, inflammation, and islet cell death
Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3
Activated protein C promotes neovascularization and neurogenesis in postischemic brain via protease-activated receptor 1
Activated protein C promotes neuroprotection: mechanisms and translation to the clinic
Activated protein C reduces graft neutrophil activation in clinical renal transplantation
Activated protein C resistance caused by Arg506Gln mutation in factor Va
Activated protein C resistance in ischemic stroke not due to factor V arginine(506)->glutamine mutation
Activated protein C resistance: molecular mechanisms
Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V
Activated protein C resistance: What have we learned now that the dust has settled?
Activated protein c signals through the thrombin receptor par1 in endothelial cells
Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity
Activated Protein C Strengthens Cardiac Tolerance to Ischemic Insults in Aging
Activated protein C targets CD8(+) dendritic cells to reduce the mortality of endotoxemia in mice
Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells
Activated protein c up-regulates procoagulant tissue factor activity on endothelial cells by shedding the tfpi kunitz 1 domain